Home › Medicine › Abbvie Inc.

Abbvie Inc.

Low risk

The FDA considers this unlikely to cause harm. Return it for a refund if you would rather not keep it.

Class III

  • Unlikely to cause any adverse health consequence, but the product breaks FDA rules.
  • Refunds don't require a receipt, and you don't need proof of purchase.
  • FDA status: Ongoing.

What was recalled

Source: FDA · synced 29 Jul 2026 13:14
Low risk Filed 2026-06-03

Failed Stability Specifications

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Check these codes: Lot # 402805, 407596, Exp Date: 08/2026.

2,736 bottles · distributed us nationwide. Recall D-0551-2026 on FDA.gov ↗
Ad slot · height reserved before load

Watch Abbvie Inc. for new recalls

One email per recall. Nothing else, ever.